Jinyeong Lim
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 2
- PARP inhibition in cancer therapy 2
-
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 2
- Co-authors
- Yoon Jung Park (4 shared papers)Anders M. Lindroth (4 shared papers)Jong Bae Park (1 shared paper)Christoph Plass (2 shared papers)So Young Yoon (1 shared paper)Jörg Fellenberg (2 shared papers)Florian Haller (2 shared papers)Soo-Jung Park (1 shared paper)
- Journals
- International Journal of Molecular Sciences (2 papers)JHEP Reports (2 papers)Clinical Cancer Research (1 paper)Cancer Research and Treatment (1 paper)Scientific Reports (1 paper)
- Partner nations
- South KoreaUnited StatesGermany
In The Last Decade
Jinyeong Lim
16 papers receiving 157 citations
Peers
Comparison fields: 5 of 40
- Cancer Research 46
- Oncology 37
- Pulmonary and Respiratory Medicine 42
- Rheumatology 17
- Molecular Biology 76
Countries citing papers authored by Jinyeong Lim
This map shows the geographic impact of Jinyeong Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyeong Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyeong Lim more than expected).
Fields of papers citing papers by Jinyeong Lim
This network shows the impact of papers produced by Jinyeong Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyeong Lim. The network helps show where Jinyeong Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinyeong Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 39 | |
| 2 | 2020 | 24 | |
| 3 | 2022 | 18 | |
| 4 | 2019 | 17 | |
| 5 | 2017 | 14 | |
| 6 | 2021 | 8 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 6 | |
| 9 | Cost-effectiveness of Afatinib versus Erlotinib in the First-line Treatment of Patients with Metastatic Non-small Cell Lung Cancer with EGFR Exon 19 Deletion Mutations | 2016 | 5 |
| 10 | 2024 | 4 | |
| 11 | 2020 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2022 | 3 | |
| 14 | 2018 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 |
About Jinyeong Lim
Jinyeong Lim is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Pathology and Forensic Medicine, having authored 18 papers that have together received 157 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (2 papers), MicroRNA in disease regulation (2 papers), Genetic factors in colorectal cancer (2 papers), PARP inhibition in cancer therapy (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (46 citations), Oncology (37 citations), Pulmonary and Respiratory Medicine (42 citations), Rheumatology (17 citations) and Molecular Biology (76 citations). Jinyeong Lim has collaborated with scholars based in South Korea, United States and Germany. Frequent co-authors include Yoon Jung Park, Anders M. Lindroth, Jong Bae Park, Christoph Plass, So Young Yoon, Jörg Fellenberg, Florian Haller, Soo-Jung Park, Hyun Guy Kang and Annika Baude. Their work appears in journals such as International Journal of Molecular Sciences, JHEP Reports, Clinical Cancer Research, Cancer Research and Treatment and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.